The Rheumatology Profile 6 (Rheumatoid Plus) Blood Test is an advanced diagnostic panel designed to assess markers associated with rheumatoid arthritis (RA) and other related autoimmune diseases. This profile provides a more comprehensive evaluation than basic rheumatoid arthritis panels, incorporating tests that detect not only classic rheumatoid factors but also other autoimmune markers that may help in identifying early, atypical, or related conditions.

Components of the Rheumatology Profile 6 (Rheumatoid Plus) Blood Test:

1. Rheumatoid Factor (RF)

  • Purpose: Measures levels of rheumatoid factor, an antibody commonly present in rheumatoid arthritis (RA).
  • Indication: Used to diagnose RA and other autoimmune conditions.
  • Abnormal Results: A positive RF test is seen in approximately 70-80% of RA patients but can also be elevated in other conditions, including Sjögren’s syndrome, chronic infections, and in some healthy individuals.

2. Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibodies

  • Purpose: Detects antibodies against cyclic citrullinated peptides, highly specific to rheumatoid arthritis.
  • Indication: Used to confirm the diagnosis of RA, especially in its early stages, and to predict disease severity and progression.
  • Abnormal Results: A positive Anti-CCP test is strongly indicative of RA and correlates with more aggressive disease.

3. C-Reactive Protein (CRP)

  • Purpose: A nonspecific marker of inflammation that rises in response to inflammatory conditions.
  • Indication: Used to assess the level of inflammation and monitor disease activity in RA and other autoimmune disorders.
  • Abnormal Results: Elevated CRP levels indicate active inflammation, which is common in RA flares or other inflammatory conditions.

Conditions Often Assessed with Rheumatology Profile 6:

  • Rheumatoid Arthritis (RA): Primary condition evaluated, especially early or atypical RA cases.
  • Sjögren’s Syndrome: Often overlaps with RA, causing joint symptoms and dry eyes/mouth.
  • Lupus (SLE): Can overlap with or mimic RA, with joint inflammation and other systemic symptoms.
  • Mixed Connective Tissue Disease (MCTD): An overlap syndrome with features of RA, lupus, and scleroderma.
  • Ankylosing Spondylitis or Psoriatic Arthritis: Seronegative arthritis conditions that can sometimes resemble RA.
  • Systemic Vasculitis: Severe forms of RA can lead to systemic vasculitis, which can involve low complement levels and other immune markers.

When Is the Rheumatology Profile 6 Test Ordered?

  • Diagnosis of Rheumatoid Arthritis: When RA is suspected but further confirmation is needed, especially if early, atypical, or seronegative forms of the disease are present.
  • Monitoring Disease Activity: In patients with confirmed RA to track inflammation and disease progression.
  • Differentiating Autoimmune Diseases: When RA symptoms overlap with those of lupus, Sjögren’s syndrome, or other autoimmune conditions.
  • Screening for Overlap Syndromes: In cases where patients present with features of multiple autoimmune diseases.

Conclusion:

The Rheumatology Profile 6 (Rheumatoid Plus) Blood Test is a comprehensive tool for diagnosing rheumatoid arthritis and distinguishing it from other autoimmune diseases. By combining classic RA markers like RF and Anti-CCP with additional autoimmune, this profile helps clinicians assess more complex or atypical presentations of arthritis and related conditions. It provides valuable insights into the underlying causes of joint inflammation and helps guide personalised treatment strategies.